Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute / Julia Etchin |
Young Investigator Grants |
2012 |
Massachusetts |
Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy |
St. Jude Children’s Research Hospital / Caitlin Zebley, MD/PhD |
Young Investigator Grants |
2021 |
Tennessee |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida / Catherine Flores, PhD |
Young Investigator Grants |
2015 |
Florida |
Immunotherapy for Osteosarcoma and Ewing sarcoma
|
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Young Investigator Grants |
2007 |
Texas |
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia |
University of Pennsylvania / Kelly Getz, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |